MFC Co., Ltd. Logo

MFC Co., Ltd.

A GMP-certified CDMO/CMO developing and manufacturing APIs for the global pharma sector.

432980 | KO

Overview

Corporate Details

ISIN(s):
KR7432980001
LEI:
Country:
South Korea
Address:
경기도 화성시 마도면 청원산단7길 35(청원리 1453), 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 2008, MFC Co., Ltd. is a pharmaceutical company specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and key intermediates. The company offers Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services tailored to the global pharmaceutical sector. As a GMP-certified manufacturer, MFC focuses on producing high-quality raw medicines and new APIs, aiming to become a global leader in pharmaceutical development and technology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 82.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.0 MB
2025-06-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 780.1 KB
2025-04-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.0 KB
2025-03-28 00:00
Board/Management Information
대표이사변경
Korean 12.3 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 28.6 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 19.1 KB
2025-03-20 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 423.5 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 85.2 KB
2025-03-07 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 16.4 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.0 KB
2025-02-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 66.5 KB

Automate Your Workflow. Get a real-time feed of all MFC Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MFC Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MFC Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bulgaria
PHRM
Pharmicell Co.,Ltd. Logo
Biopharma firm in stem cell therapies, biochemicals, cell banking, and stem cell cosmetics.
South Korea
005690
Pharming Group N.V. Logo
Develops & commercializes protein & precision medicines for rare, life-threatening diseases.
Netherlands
PHARM
Pharmocann Global Ltd. Logo
Develops pharma-grade medical cannabis products like oils, ointments, tablets, and cosmetics.
Israel
PMCN-M
Pharvaris N.V. Logo
Developing oral therapies for rare angioedema to treat and prevent attacks.
United States of America
PHVS
Phathom Pharmaceuticals, Inc. Logo
Develops and commercializes treatments for acid-related gastrointestinal diseases.
United States of America
PHAT
Pherecydes Pharma Logo
Develops precision phage therapy to treat resistant bacterial infections.
France
ALPHE
PHIBRO ANIMAL HEALTH CORP Logo
Develops animal health products, vaccines, and nutrition for livestock and companion animals.
United States of America
PAHC
Philogen Logo
Developing targeted biopharmaceuticals for oncology using proprietary ligand-based delivery.
Italy
PHIL
Phio Pharmaceuticals Corp. Logo
Developing RNAi-based immuno-oncology therapeutics for melanoma and other skin cancers.
United States of America
PHIO

Talk to a Data Expert

Have a question? We'll get back to you promptly.